NEW!!! Handbook on Agriculture, Biotechnology and Development by Smyth, Phillips and Castle

Tags

Agricultural Biotechnology, development, economics, impacts, socioeconomics

Advances in plant genomics in the 1980s and early 1990s resulted in the commercialization of genetically modified crops 20 years ago. The adoption, production and international trade of GM crops created unprecedented levels of debate and dialogue about modern society’s relationship with its food and how it is produced. While some within the agricultural biotechnology community predicted that these discussions would quickly fade away, concerns, outrages, myths and mis-information continue to abound. An attempt to provide some needed clarity to this discourse will shortly be available in the new Handbook on Agriculture, Biotechnology and Development. Through the collaborative efforts of 50 international experts, the editors provide a diverse, but concentrated, global perspective on biotechnology applications to plant agriculture.

Contents:

Editor’s Introduction: Conceptual Framing of the IAD framework and Methods, Models and Metrics

1. Introduction to Agriculture, Biotechnology and Development
Stuart J. Smyth, Peter W.B. Phillips and David Castle

PART I: EXOGENOUS VARIABLES: THE ENVIRONMENT, ACTORS AND RULES
2. Global Adoption of GM Crops, 1995–2012
Graham Brookes

3. Structure of Public Research
Richard Gray and Buwani Dayananda

4. The Private Sector: MNEs and SMEs
Jill E. Hobbs

5. Biotechnology in North America: The United States, Canada and Mexico
Julia Bognar and Grace Skogstad

6. South American Adopters: Argentina and Brazil
Sybil D. Rhodes

7. Africa
Jennifer Thomson

8. China
Valerie Karplus

9. Agricultural Biotechnology in India: Impacts and Controversies
Matin Qaim

10. Oceania: Australia, New Zealand, Japan and The Philippines
Karinne Ludlow and Jose Yorobe Jr.

11. European Union Policy Conflicts over Agbiotech: Ecological Modernisation Perspectives and Critiques
Les Levidow

12. Africa Non-adopters
Robert Paarlberg

13. Non-adopters of GM Crops in Latin American
Jose Falck-Zepeda

14. The Cuban Context for Agriculture and Innovation
Carlos G. Borroto

15. Risk Assessment Frameworks in the Multilateral Setting
Lee Ann Jackson

16. The Trade System and Biotechnology
William A. Kerr

17. Developing Countries and the Legal Institutions at the Intersection of Agbiotech and Development
Chidi Oguamanam

18. Consumer Attitudes and Preferences for GM Products
Stuart Smyth and David Castle

19. The Motivation and Impact of Organized Public Resistance Against Agricultural Biotechnology
Philip Aerni

PART II: ACTION ARENAS
20. The Research Pipeline
Peter Phillips

21. Clusters, Innovation Systems and Biotechnology in Developing Country Agriculture
David Spielman, Douglas Zhihua Zeng and Xingliang Ma

22. Practice Driving Policy: Agbiotech Transfer as Capacity Building
William O. Hennessey, Aarushi Gupta and Stanley P. Kowalski

23. The North American Crop Biotech Environment, Actors and Rules
David Schimmelpfennig

24. Adoption Decisions
Corinne Alexander

25. Co-existence
Volker Beckmann, Claudio Soregaroli and Justus Wesseler

26. Biotechnology and the Inputs Industry
Anwar Naseem and Latha Nagarajan

27. Measuring Market Power in the US Biotech Industry
Alexandre Magnier, Nicholas Kalaitzandonakes and Douglas Miller

28. The Dynamic IP System in Crop Genetics and Biotechnology
Derek Eaton and Greg Graff

29. Environment Effects
LaReesa Wolfenbarger, Yves Carrière and Micheal Owen

30. Labelling of Genetically Modified Foods
Wallace E. Huffman and Jill J. McCluskey

31. Biotechnology and Food Security
Calestous Juma, Pedro Conceição and Sebastian Levine

32. International Regimes on Plant Intellectual Property Rights and Plant Genetic Resources: Implications for Stakeholders
Deepthi Elizabeth Kolady

33. Democratic Engagement
Jennifer Medlock and Edna Einsiedel

34. Lessons from the California GM Labelling Proposition on the State of Crop Biotechnology
David Zilberman, Scott Kaplan, Eunice Kim and Gina Waterfield

35. Biotechnology Communications, Mythmaking and the Media
Camille D. Ryan

PART III: OUTCOMES
36. Soybeans
Jorge Fernandez-Cornejo and Seth Wechsler

37. Maize/Corn
Janet Carpenter, Marnus Gouse and Jose Yorobe Jr.

38. GM Cotton
Jeffrey Vitale, Gaspard Vognan and Marc Ouattarra

39. Canola
Derek Brewin and Stavroula Malla

40. The Hawaiian Papaya Story
Carol and Dennis Gonsalves

41. Sugar Beet
Koen Dillen and Matty Demont

42. Rice
Matty Demont, Mao Chen, Gongyin Ye and Alexander J. Stein

43. Aggregate Effects: Adopters and Non-adopters, Investors and Consumers
George Frisvold and Jeanne M. Reeves

44. Economic Success but Political Failure? The Paradox of GM Crops in Developing Countries
Terri Raney, Ademola A. Adenle and Ira Matuschke

45. The Size and Distribution of the Benefits from the Adoption of Biotech Soybean Varieties
Julian Alston, Nicholas Kalaitzandonakes and John Kruse

46. GM Wheat: Status, Outlook and Implications
William W. Wilson

47. Small Grains: Barley, Oat and Rye
Syed Masood H. Rizvi and Graham J. Scoles

48. Incremental Benefits of Genetically Modified Bananas in Uganda
Enoch M. Kikulwe, Jose Falck-Zepeda and Justus Wesseler

49. Biofuels and GM Feedstocks
Alphanso Williams and William A. Kerr

50. Non-food GM Crops: Phytoremediation, Industrial Products and Pharmaceuticals
George G. Khachatourians

51. Tomatoes, Potatoes and Flax: Exploring the Cost of Lost Innovations
Camille D. Ryan and Alan McHughen

To view information about this book from Edward Elgar…please click here

Consequences of socio-economic inclusion in decision making: Potential regulatory delays can have a major impact in terms of economic benefits to society

Tags

Biosafety, cost of compliance, impacts, Philippines

Bt/RR maize Isabela province, The Philippines. (c) J. Falck-Zepeda 2011

In a paper that I co-wrote with Jessica Bayer and George Norton (Bayer, Norton and Falck Zepeda 2010) we showed in a simple experiment that delays can have a big impact on the net benefits from four genetically engineered applications in the Philippines.

In this paper, we showed that even small delays of three years compared to the baseline can decrease significantly the present value of net benefits to producers. In turn, increases in cost of compliance had a very small effect on net benefits.

Contrary to the case study we did for the black sigatoka bananas in Uganda (see the Kikulwe et al. paper in the references), in the Philippines exercise we did not consider the potential gains from waiting and conducting more experiments and thus gain additional knowledge. The later is an important limitation for the type of exercise we conducted in the Philippines.

The value of examining potential losses from regulatory delays is connecting the cost of compliance with biosafety regulations to the potential costs and benefits derived from technology adoption.

The lesson learned here is that it is prudent for policy/regulatory and other decision makers to examine the impacts of regulations, especially from the standpoint of considering all gains, costs and risks to society as a whole. This includes, obviously, impacts at the producer, consumer and other actors is society.

References